	2024	2025	2026	2027	2028
Revenue	15,255	15,418	15,949	16,043	-
Dividend	1.18	1.20	1.21	1.32	-
Dividend Yield (in %)	6.41 %	6.54 %	6.57 %	7.20 %	6.38 %
EPS	1.61	1.75	1.98	2.28	-
P/E Ratio	11.38	10.51	9.27	8.03	10.31
EBIT	1,068	1,170	1,322	1,565	-
EBITDA	2,100	2,218	2,384	2,600	-
Net Profit	725	795	919	1,063	-
Net Profit Adjusted	725	795	919	1,063	-
Pre-Tax Profit	891	1,075	1,244	1,549	-
Pre-Tax Profit Reported	735	1,053	1,220	1,435	-
EPS (Non-GAAP) ex. SOE	-	-	-	-	-
EPS (GAAP)	1.09	1.52	1.76	2.07	-
Gross Income	3,581	3,719	3,932	-	-
Cash Flow from Investing	-692	-777	-795	-	-
Cash Flow from Operations	1,601	1,773	1,858	2,319	-
Cash Flow from Financing	-883	-823	-852	-	-
Cash Flow per Share	3.43	3.58	3.88	3.72	-
Free Cash Flow	739	855	920	1,034	-
Free Cash Flow per Share	1.46	1.68	1.77	1.67	-
Book Value per Share	19.14	19.57	20.25	20.40	-
Net Debt	3,730	3,438	3,112	2,870	-
Research & Development Exp.	452	448	463	-	-
Capital Expenditure	750	794	821	799	-
Selling, General & Admin. Exp.	2,627	2,381	2,464	-	-
Shareholder’s Equity	8,979	9,103	9,415	9,545	-
Total Assets	19,614	19,530	19,633	-	-

	Previous Quarter ending 09/30/24	Current Quarter ending 12/31/24	Next Quarter ending 03/31/25	Current Year ending 12/31/24	Next Year ending 12/31/25
Earnings Estimates
No. of Analysts	7	6	3	16	16
Average Estimate	0.487 EUR	0.216 EUR	0.411 EUR	1.612 EUR	1.745 EUR
Year Ago	-0.206 EUR	-0.313 EUR	0.335 EUR	-0.998 EUR	-
Publish Date	11/6/2024	3/5/2025	5/12/2025	5/28/2025	-
Revenue Estimates
No. of Analysts	6	4	2	15	15
Average Estimate	3,908 EUR	3,676 EUR	3,908 EUR	15,255 EUR	15,418 EUR
Year Ago	3,771 EUR	3,605 EUR	3,796 EUR	15,267 EUR	-
Publish Date	11/6/2024	3/5/2025	5/12/2025	5/28/2025	-

* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. EUR

	2023	2022	2021	2020	2019	2018	2017
Sales	15,267.00	18,488.00	14,955.00	12,199.00	13,108.00	15,024.00	14,419.00
Change of sales in %	-17.42	23.62	22.59	-6.93	-12.75	4.20	13.25
Gross profit on sales	3,391.00	4,266.00	4,063.00	3,366.00	3,695.00	4,625.00	4,481.00
Gross profit on sales change in %	-20.51	5.00	20.71	-8.90	-20.11	3.21	6.74
Operating income	615.00	1,190.00	1,307.00	922.00	1,244.00	1,834.00	1,579.00
Operating income change in %	-48.32	-8.95	41.76	-25.88	-32.17	16.15	27.65
Income before tax	-361.00	911.00	1,077.00	669.00	949.00	1,194.00	1,017.00
Income before tax change in %	-	-15.41	60.99	-29.50	-20.52	17.40	-12.55
Income after tax	-465.00	539.00	748.00	489.00	753.00	930.00	717.00
Income after tax change in %	-	-27.94	52.97	-35.06	-19.03	29.71	-4.14

Balance Sheet in Mio. EUR

	2023	2022	2021	2020	2019	2018	2017
Total liabilities	12,277.00	12,148.00	14,082.00	14,081.00	14,236.00	13,749.00	13,573.00
Long-term liabilities per share	17.66	18.24	21.65	23.76	22.84	22.16	21.83
Equity	8,986.00	11,056.00	9,372.00	8,099.00	9,060.00	7,825.00	7,527.00
Equity change in %	-18.81	18.14	15.94	-10.68	16.06	3.90	-2.86
Balance sheet total	21,263.00	23,204.00	23,454.00	22,180.00	23,296.00	21,574.00	21,100.00
Balance sheet total change in %	-8.36	-1.07	5.74	-4.79	7.98	2.25	0.84

Key Data in EUR

	2023	2022	2021	2020	2019	2018	2017
Sales per share	32.76	39.67	32.09	26.18	28.13	32.24	30.94
P/E ratio (year end quote, basic EPS)	-	15.51	17.78	25.07	15.41	10.90	20.37
P/E ratio (year end quote, diluted EPS)	-	15.51	17.78	25.07	15.41	10.90	20.37
P/E ratio (year end quote)	-	15.51	17.78	25.07	15.41	10.90	20.37
Dividend yield in %	6.32	6.52	4.11	4.31	4.23	5.28	3.67
Equity ratio in %	42.26	47.65	39.96	36.51	38.89	36.27	35.67
Debt ratio in %	57.74	52.35	60.04	63.49	61.11	63.73	64.33

Evonik Dividend Calendar

Date	Name	Dividend	*yield	Currency
2023	Evonik AG	1.17	6.32	EUR
2022	Evonik AG	1.17	6.52	EUR
2021	Evonik AG	1.17	4.11	EUR
2020	Evonik AG	1.15	4.31	EUR
2019	Evonik AG	1.15	4.23	EUR
2018	Evonik AG	1.15	5.28	EUR
2017	Evonik AG	1.15	3.67	EUR
2016	Evonik AG	1.15	4.05	EUR
2015	Evonik AG	1.15	3.76	EUR
2014	Evonik AG	1.00	3.69	EUR
2013	Evonik AG	1.00	3.37	EUR
2012	Evonik AG	-	-	EUR
2011	Evonik AG	-	-	EUR
2010	Evonik AG	-	-	EUR
2009	Evonik AG	-	-	EUR

*Yield of the Respective Date

Evonik Calendar

Event	Estimate	Info	Date
Earnings Report	0.216 EUR	Q4 2024 Earnings Release	03/05/2025
Earnings Report	0.412 EUR	Q1 2025 Earnings Release	05/12/2025
Annual General Meeting	-	Annual General Meeting	05/28/2025
Earnings Report	0.461 EUR	Q2 2025 Earnings Release	08/01/2025
Earnings Report	0.530 EUR	Q3 2025 Earnings Release	11/11/2025
Earnings Report	0.350 EUR	Q4 2025 Earnings Release	03/10/2026
Earnings Report	-	Q1 2026 Earnings Release	05/12/2026
Earnings Report	-	Q2 2026 Earnings Release	07/30/2026

Evonik Past Events

Event	Actual EPS	Info	Date
Earnings Report	0.480 EUR	Q3 2024 Earnings Release	11/06/2024
Earnings Report	0.230 EUR	Q4 2021 Earnings Release	03/03/2022

Evonik Profile

Evonik Industries AG operates as a holding company, which manufactures specialty chemical products. It operates through the following segments: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives segment includes powerful additives and versatile crosslinkers. The Nutrition & Care segment provides products for human well-being and the quality of life. The Smart Materials segment includes businesses with innovative materials that enable resource-saving solutions and replace conventional materials. The Performance Materials segment brings together businesses with the same DNA and it focuses on resource-saving production, new applications and specialties. The Technology & Infrastructure segment provides services which are required across the asset lifecycle of chemical production plants. The company was founded in 1919 and is headquartered in Essen, Germany.

Moody’s Daily Credit Risk Score

Risk

Low
Medium
High

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Evonik Shareholder

Owner	in %
RAG-Stiftung	53.00
Freefloat	42.01
AVGP Ltd.	4.99
Bridge Builder International Equity Fund	1.72
American Funds Global Balanced Fund	1.18
Government Pension Fund - Global (The)	0.87
Vanguard Total International Stock Index Fund	0.74
John Hancock Disciplined Value International Fund	0.57

Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

Evonik Management

Name	Job
Christian Kullmann	Chairman-Management Board
Bernd Tönjes	Chairman-Supervisory Board
Maike Schuh	Chief Financial Officer
Thomas Wessel	Chief HR Officer & Director-Labor Relations
Kai Kirchhoff	Director-Financial Planning & Reporting
Yann d'Herve	Head-Care Sol Business Line, Nutrition Care Div
Tim Lange	Head-Investor Relations
Angela Titzrath	Independent Member-Supervisory Board
Aldo Belloni	Independent Member-Supervisory Board
Barbara Ruth Albert	Independent Member-Supervisory Board
Ariane Reinhart	Member-Supervisory Board
Thomas Meiers	Member-Supervisory Board
Alexandra Boy	Member-Supervisory Board
Cedrik Neike	Member-Supervisory Board
Cornelius Baur	Member-Supervisory Board
Martin Kubessa	Member-Supervisory Board
Martina Reisch	Member-Supervisory Board
Gerd Schlengermann	Member-Supervisory Board
Christian Kohlpaintner	Member-Supervisory Board
Hussin El Moussaoui	Member-Supervisory Board
Michael Rüdiger	Member-Supervisory Board
Gerhard Ribbeheger	Member-Supervisory Board
Werner Fuhrmann	Member-Supervisory Board
Alexandra Krieger	Member-Supervisory Board
Martin Albers	Member-Supervisory Board
Anke Dassler	Senior Vice President-Human Resources
Harald Schwager	Vice Chairman-Management Board
Alexander Bercht	Vice Chairman-Supervisory Board